Relevance of genetic alterations in squamous and small cell lung cancer.

about

Relevance of genetic alterations in squamous and small cell lung cancer.

Item

http://www.wikidata.org/entity/Q44483486

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Relevance of genetic alterations in squamous and small cell lung cancer.

@en

Relevance of genetic alterations in squamous and small cell lung cancer.

@nl

type

Item

label

Relevance of genetic alterations in squamous and small cell lung cancer.

@en

Relevance of genetic alterations in squamous and small cell lung cancer.

@nl

prefLabel

Relevance of genetic alterations in squamous and small cell lung cancer.

@en

Relevance of genetic alterations in squamous and small cell lung cancer.

@nl

P1476

Relevance of genetic alterations in squamous and small cell lung cancer.

@en

P2093

Joshua K Sabari

http://www.w3.org/2001/XMLSchema#string

Paul K Paik

http://www.w3.org/2001/XMLSchema#string

P2860

The Hallmarks of Cancer

Small molecule inhibitors of aurora-a induce proteasomal degradation of N-myc in childhood neuroblastoma

Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer.

Inhibitor-sensitive FGFR1 amplification in human non-small cell lung cancer.

Mutations in the DDR2 kinase gene identify a novel therapeutic target in squamous cell lung cancer.

FGFR1 mRNA and protein expression, not gene copy number, predict FGFR TKI sensitivity across all lung cancer histologies.

Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion

p53, the cellular gatekeeper for growth and division

Discoidin domain receptor 2 interacts with Src and Shc following its activation by type I collagen

Phase I/IIa study evaluating the safety, efficacy, pharmacokinetics, and pharmacodynamics of lucitanib in advanced solid tumors

P304

373

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.21037/ATM.2017.06.72

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29057233

http://www.w3.org/2001/XMLSchema#string

P932

5635252

http://www.w3.org/2001/XMLSchema#string